Table 2 Biochemical, virological, serological responses and APRI change after bicyclol treatment
variable | All patients (n = 123) | Normal ALT (n = 38) | Elevated ALT (n = 85) |
|---|---|---|---|
ALT≤1 × upper limit of normal, n(%) | 107 (87.0) | 37 (97.4) | 70 (82.4) |
HBeAg loss, n(%) | 11 (16.7) | 2 (22.2) | 9 (15.8) |
HBV DNA (mean ± SD), log10IU/ml | |||
Pre-treatment | 5.99 ± 1.76 | 4.43 ± 1.79 | 6.67 ± 1.24 |
Post-treatment | 5.20 ± 1.77* | 4.23 ± 1.66 | 5.76 ± 1.59* |